Previous studies have shown that cytokine imbalances—including IL-10, IL-6, IL-4, and IL-17—are associated with aberrant activation of the NF-κB pathway in active RA, contributing to systemic inflammation and a prothrombotic state [44]. The gene discussed is IL6; the disease is rheumatoid arthritis.